{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.138G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "138"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        },
        {
          "HGVS": "NM_001126112.3:c.89G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "89"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_001126112.3:c.158G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        },
        {
          "HGVS": "NM_001126112.3:c.89G>A,NM_001126112.3:c.158G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G,G",
            "alt": "A,A",
            "position": "89,158"
          },
          "Protein Change": {
            "ref": "A,A",
            "alt": "P,T",
            "position": "30,53"
          },
          "Description in input context": "A30P/A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Lewy body disease",
    "MONDO": "MONDO:0005331"
  },
  "Experiment Method": [
    {
      "Assay Method": "Thioflavin S assay",
      "Material used": {
        "Material Source": "Recombinant α-synuclein proteins",
        "Material Name": "α-synuclein",
        "Description": "Recombinant α-synuclein proteins were used for fibril formation analysis."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.138G>A",
          "Conclusion": "Accelerated",
          "Molecular Effect": "Increased fibril formation kinetics",
          "Result Description": "E46K variant showed accelerated fibril formation."
        },
        {
          "Variant": "NM_001126112.3:c.89G>A",
          "Conclusion": "Decelerated",
          "Molecular Effect": "Reduced fibril formation kinetics",
          "Result Description": "A30P variant showed decelerated fibril formation."
        },
        {
          "Variant": "NM_001126112.3:c.158G>A",
          "Conclusion": "Decelerated",
          "Molecular Effect": "Reduced fibril formation kinetics",
          "Result Description": "A53T variant showed decelerated fibril formation."
        },
        {
          "Variant": "NM_001126112.3:c.89G>A,NM_001126112.3:c.158G>A",
          "Conclusion": "Decelerated",
          "Molecular Effect": "Reduced fibril formation kinetics",
          "Result Description": "A30P/A53T compound variant showed decelerated fibril formation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer or non-protein controls were used."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal fibril formation kinetics observed in wild-type controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation from wild-type fibril formation kinetics.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Circular dichroism (CD) spectroscopy",
      "Material used": {
        "Material Source": "Recombinant α-synuclein proteins",
        "Material Name": "α-synuclein",
        "Description": "Recombinant α-synuclein proteins were used for secondary structure analysis."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.138G>A",
          "Conclusion": "Altered",
          "Molecular Effect": "Changes in secondary structure",
          "Result Description": "E46K variant showed altered secondary structure."
        },
        {
          "Variant": "NM_001126112.3:c.89G>A",
          "Conclusion": "Altered",
          "Molecular Effect": "Changes in secondary structure",
          "Result Description": "A30P variant showed altered secondary structure."
        },
        {
          "Variant": "NM_001126112.3:c.158G>A",
          "Conclusion": "Altered",
          "Molecular Effect": "Changes in secondary structure",
          "Result Description": "A53T variant showed altered secondary structure."
        },
        {
          "Variant": "NM_001126112.3:c.89G>A,NM_001126112.3:c.158G>A",
          "Conclusion": "Altered",
          "Molecular Effect": "Changes in secondary structure",
          "Result Description": "A30P/A53T compound variant showed altered secondary structure."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer or non-protein controls were used."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal secondary structure observed in wild-type controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation from wild-type secondary structure.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Electron microscopy (EM) and atomic force microscopy (AFM)",
      "Material used": {
        "Material Source": "Recombinant α-synuclein proteins",
        "Material Name": "α-synuclein",
        "Description": "Recombinant α-synuclein proteins were used for morphological analysis."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.138G>A",
          "Conclusion": "Altered morphology",
          "Molecular Effect": "Changes in fibril morphology",
          "Result Description": "E46K variant showed altered fibril morphology."
        },
        {
          "Variant": "NM_001126112.3:c.89G>A",
          "Conclusion": "Altered morphology",
          "Molecular Effect": "Changes in fibril morphology",
          "Result Description": "A30P variant showed altered fibril morphology."
        },
        {
          "Variant": "NM_001126112.3:c.158G>A",
          "Conclusion": "Altered morphology",
          "Molecular Effect": "Changes in fibril morphology",
          "Result Description": "A53T variant showed altered fibril morphology."
        },
        {
          "Variant": "NM_001126112.3:c.89G>A,NM_001126112.3:c.158G>A",
          "Conclusion": "Altered morphology",
          "Molecular Effect": "Changes in fibril morphology",
          "Result Description": "A30P/A53T compound variant showed altered fibril morphology."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer or non-protein controls were used."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal fibril morphology observed in wild-type controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation from wild-type fibril morphology.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}